Subscribe To Our Free Newsletter |
Shares of Concord Biotech ends 27% higher in debut at $1 bn valuation
The Ahmedabad, Gujarat-based company opened at 900.05 rupees, a 21.5% premium to its initial public offer (IPO) price of 741 rupees